[175] An observational study on people with obesity and type 2 diabetes and heart failure with preserved ejection fraction, semaglutide had about a 42% lower risk of hospitalization for heart failure and all-cause death combined compared with sitagliptin
DEXA body composition tracking to monitor fat and muscle Hormone testing to understand your specific patterns Sleep and stress assessment (often overlooked factors) Protein and nutrition guidance for metabolism support Optional HRT discussion if symptoms warrant Many women find that addressing weight with compounded semaglutide also improves other perimenopausal symptomsbetter sleep, more stable mood, and increased energy as the burden of excess weight decreases
Research suggests both approaches produce comparable weight loss results over the long term, typically after twelve months
Sustained Hypertension Venlafaxine treatment is associated with sustained increases in blood pressure in some patients
Jennifer Ashton, ABC News chief medical correspondent and a board-certified obesity medicine specialist, said on "Good Morning America." Those with obesity may struggle to manage long-term weight loss with changes in diet and exercise alone